142 related articles for article (PubMed ID: 19537424)
1. Seroprevalence of varicella zoster antibodies among children with malnutrition, malignancies and HIV infection.
Admani B; Macharia WM; Were F
East Afr Med J; 2008 Oct; 85(10):480-6. PubMed ID: 19537424
[TBL] [Abstract][Full Text] [Related]
2. Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany.
Wiese-Posselt M; Siedler A; Mankertz A; Sauerbrei A; Hengel H; Wichmann O; Poethko-Müller C
BMC Infect Dis; 2017 May; 17(1):356. PubMed ID: 28525973
[TBL] [Abstract][Full Text] [Related]
3. Nosocomial transmission of chickenpox and varicella zoster virus seroprevalence rate amongst healthcare workers in a teaching hospital in China.
Yang J; Liu J; Xing F; Ye H; Dai G; Liu M; Lo SK; Lau RW; Chiu KH; Chan JF; Yuen KY
BMC Infect Dis; 2019 Jul; 19(1):582. PubMed ID: 31277589
[TBL] [Abstract][Full Text] [Related]
4. Seroepidemiology of varicella-zoster virus infection in a cosmopolitan city (Erzurum) in the eastern Turkey.
Alp H; Altinkaynak S; Ertekin V; Kiliçaslan B; Giiraksin A
Health Policy; 2005 Apr; 72(1):119-24. PubMed ID: 15760704
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of varicella-zoster virus in Polish population.
Siennicka J; Trzcińska A; Rosińska M; Litwińska B
Przegl Epidemiol; 2009; 63(4):495-9. PubMed ID: 20120946
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of varicella-zoster virus among pregnant women in Fayoum Governorate, Egypt.
Ibrahim EG; Abdel Wahed WY; Eid HM; Deeb WS
J Egypt Public Health Assoc; 2019; 94(1):2. PubMed ID: 30686830
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico.
Conde-Glez C; Lazcano-Ponce E; Rojas R; DeAntonio R; Romano-Mazzotti L; Cervantes Y; Ortega-Barria E
Vaccine; 2013 Oct; 31(44):5067-74. PubMed ID: 24021305
[TBL] [Abstract][Full Text] [Related]
8. A seroepidemiologic survey of the prevalence of varicella-zoster virus in the pediatric population in two university hospitals in Brazil.
Semenovitch I; Lupi O
Int J Dermatol; 2003 Mar; 42(3):193-6. PubMed ID: 12653913
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of IgG varicella zoster virus antibodies in the Kuikuro and Kaiabi indigenous communities in Xingu National Park, Brazil, before varicella vaccination.
Lafer MM; de Moraes-Pinto MI; Weckx LY
Rev Inst Med Trop Sao Paulo; 2005; 47(3):139-42. PubMed ID: 16021286
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of varicella-zoster virus in the German population.
Wutzler P; Färber I; Wagenpfeil S; Bisanz H; Tischer A
Vaccine; 2001 Oct; 20(1-2):121-4. PubMed ID: 11567755
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity.
Heininger U; Braun-Fahrländer C; Desgrandchamps D; Glaus J; Grize L; Wutzler P; Schaad UB;
Pediatr Infect Dis J; 2001 Aug; 20(8):775-8. PubMed ID: 11734740
[TBL] [Abstract][Full Text] [Related]
12. How reliable is the history of chickenpox? Varicella serology among children up to 14 years of age.
Kavaliotis J; Petridou S; Karabaxoglou D
Int J Infect Dis; 2003 Dec; 7(4):274-7. PubMed ID: 14656418
[TBL] [Abstract][Full Text] [Related]
13. Changes in age related seroprevalence of antibody to varicella zoster virus: impact on vaccine strategy.
Kudesia G; Partridge S; Farrington CP; Soltanpoor N
J Clin Pathol; 2002 Feb; 55(2):154-5. PubMed ID: 11865016
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population.
van Rijckevorsel GG; Damen M; Sonder GJ; van der Loeff MF; van den Hoek A
BMC Infect Dis; 2012 Jun; 12():140. PubMed ID: 22721551
[TBL] [Abstract][Full Text] [Related]
15. Occupational risk of infection by varicella zoster virus in Belgian healthcare workers: a seroprevalence study.
Vandersmissen G; Moens G; Vranckx R; de Schryver A; Jacques P
Occup Environ Med; 2000 Sep; 57(9):621-6. PubMed ID: 10935943
[TBL] [Abstract][Full Text] [Related]
16. Varicella seroprevalence in Turkish population in Cyprus.
Kurugol Z; Koturoglu G; Aksit S; Ozacar T
Acta Paediatr; 2007 Jun; 96(6):861-3. PubMed ID: 17465984
[TBL] [Abstract][Full Text] [Related]
17. Seroepidemiology of varicella-zoster virus in Korea.
Lee H; Cho HK; Kim KH
J Korean Med Sci; 2013 Feb; 28(2):195-9. PubMed ID: 23400233
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age.
Heininger U; Desgrandchamps D; Schaad UB
Vaccine; 2006 Apr; 24(16):3258-60. PubMed ID: 16459000
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence and force of infection of varicella-zoster virus in Luxembourg.
Mossong J; Putz L; Schneider F
Epidemiol Infect; 2004 Dec; 132(6):1121-7. PubMed ID: 15635970
[TBL] [Abstract][Full Text] [Related]
20. Analysis of factors associated with varicella-zoster virus susceptibility among children 0-12 years old in Taiwan.
Chang CK; Tan HF; Tseng HF; Lin CC
Med Mal Infect; 2007 Apr; 37(4):222-8. PubMed ID: 17368781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]